| NDC Code | 12064-009-00 |
|---|
| Package Description | 1 VIAL in 1 CARTON (12064-009-00) > 1.5 mL in 1 VIAL |
|---|
| Product NDC | 12064-009 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Benlysta |
|---|
| Non-Proprietary Name | Belimumab |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20110310 |
|---|
| Marketing Category Name | APPROVED DRUG PRODUCT MANUFACTURED UNDER CONTRACT |
|---|
| Application Number | BLA125370 |
|---|
| Manufacturer | GlaxoSmithKline Manufacturing SpA |
|---|
| Substance Name | BELIMUMAB |
|---|
| Strength | 120 |
|---|
| Strength Unit | mg/1.5mL |
|---|
| Pharmacy Classes | Decreased B Lymphocyte Activation [PE],B Lymphocyte Stimulator-specific Inhibitor [EPC],B Lymphocyte Stimulator-directed Antibody Interactions [MoA] |
|---|